Press releaseGlobe Newswire
Lipella Pharmaceuticals
LIPO · NASDAQ
$0.0005+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.
Latest news
- Press releasePRNewswire
Lipella Pharmaceuticals to Present at Zacks SCR Life Sciences Virtual Investor Forum and Report Final Phase 2a Results in Oral Lichen Planus
- Press releaseGlobe Newswire
Lipella Pharmaceuticals Issues Letter from the CEO to Stockholders Following Nasdaq Delisting
- NewsAvi Kapoor
Crude Oil Falls 1%; US Services PMI Declines In June
- NewsAvi Kapoor
Dow Jumps Over 200 Points; FactSet Research Shares Gain After Q3 Results
- Press releaseGlobe Newswire
Lipella Pharmaceuticals Announces Delisting from Nasdaq Capital Market
- Press releaseGlobe Newswire
Lipella Pharmaceuticals Announces U.S. Patent Issuance for Diagnostic Technology
- Press releaseGlobe Newswire
Lipella Pharmaceuticals Re-signs Manufacturing Collaboration Agreement with Cook MyoSite to Support LP-310 Clinical Development
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- Press releaseGlobe Newswire
Lipella Pharmaceuticals to Present Phase 2a Data for LP-310 in Oral Lichen Planus at 2025 AAOM/EAOM International Meeting
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- Press releaseGlobe Newswire
Lipella Pharmaceuticals Abstract on Oral Lichen Planus Treatment Accepted for Podium Presentation at 2025 AAOM/EAOM International Meeting Conference on "Global Transformation in Oral Medicine"
- Press releaseGlobe Newswire
Lipella Reports Positive Phase 2a Results from Second LP-310 Cohort in Oral Lichen Planus; Final Data Expected Q2 2025
- Press releaseGlobe Newswire
Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- NewsVandana Singh
Nano Cap Lipella Pharmaceuticals Stock Jumps On Positive Trial Data In Patients With Sore Mouth Membranes
- News
Market-Moving News for February 11th
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsAvi Kapoor
Dow Dips 150 Points; Bristol Myers Squibb Issues Weak Outlook
- NewsAvi Kapoor
Dow Edges Higher; US Weekly Jobless Claims Increase
- News
Market-Moving News for February 6th
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseGlobe Newswire
PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month
- Press releaseGlobe Newswire
Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference
- NewsAvi Kapoor
Dow Edges Lower; Ventyx Biosciences Shares Plummet
- NewsAvi Kapoor
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
- NewsAvi Kapoor
Crude Oil Moves Lower; NLS Pharmaceutics Shares Jump
- NewsErica Kollmann
Why Lipella Pharmaceutical Shares Are Soaring Today
- NewsAvi Kapoor
Nasdaq Gains 1%; McDonald's Posts Downbeat Results
- News
Market-Moving News for July 29th
- Press releaseGlobe Newswire
Lipella Pharmaceuticals Initiates Phase 2a Trial for LP-310 in Oral Lichen Planus, Enrolls First Patients
- NewsAvi Kapoor
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
- NewsAvi Kapoor
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.